Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Duplication”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03077308
What this trial is testing

Rare Diseases Clinical Research Network: Neurophysiological Correlates

Who this might be right for
Rett Syndrome, Preserved Speech VariantMecp2 Duplication SyndromeRett-related Disorders
University of Alabama at Birmingham 185
Not applicableUnknownNCT01487616
What this trial is testing

Prevalence of Congenital Uterine Malformations

Who this might be right for
Congenital Uterine Anomalies
University of Nottingham 246
Not applicableStudy completedNCT02699190
What this trial is testing

LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Who this might be right for
LeukodystrophyWhite Matter Disease4H Syndrome+61 more
Children's Hospital of Philadelphia 236
Not applicableLooking for participantsNCT07469566
What this trial is testing

Characterization of the Natural History of Microduplication Syndrome 7q11.23

Who this might be right for
7q11.23 Microduplication Syndrome (7DUP)Autism Spectrum Disorder (ASD)Neurodevelopmental Disorders (NDD)
Hospices Civils de Lyon 15
Testing effectiveness (Phase 2)Study completedNCT04240314
What this trial is testing

AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications.

Who this might be right for
Duchenne Muscular Dystrophy
Megan Waldrop 3
Testing effectiveness (Phase 2)Study completedNCT04179409
What this trial is testing

A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications.

Who this might be right for
Duchenne Muscular Dystrophy
Kevin Flanigan 3
Not applicableLooking for participantsNCT07263984
What this trial is testing

Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum.

Who this might be right for
Uterine Septum
University Hospital, Ghent 145
Testing effectiveness (Phase 2)Study completedNCT01892371
What this trial is testing

Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
FLT3 Gene Mutation NegativeFLT3 Internal Tandem Duplication PositiveRecurrent Acute Myeloid Leukemia+5 more
M.D. Anderson Cancer Center 73
Testing effectiveness (Phase 2)Study completedNCT01477606
What this trial is testing

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 451
Not applicableStudy completedNCT04449640
What this trial is testing

Uterine Rupture After Hysteroscopic Septum Resection

Who this might be right for
Septum; UterusRupture, Uterine
Università degli Studi dell'Insubria 3,000
Not applicableStudy completedNCT06924437
What this trial is testing

Evaluation of the Uterine Cavity After Operative Hysteroscopy

Who this might be right for
InfertilityAbnormal Uterine Bleeding (AUB)Intrauterine Adhesion+4 more
Sohag University 50
Not applicableStudy completedNCT02201862
What this trial is testing

Non-Invasive Chromosomal Evaluation of Trisomy Study

Who this might be right for
AneuploidyTrisomy 21Trisomy 18+2 more
Cindy Cisneros 2,000
Not applicableUnknownNCT04051086
What this trial is testing

Quantification of Elastin Markers Synthesis in Williams-Beuren Syndrome and 7q11.23 Micro-duplication Syndrome

Who this might be right for
Williams-Beuren SyndromeMicro-duplication 7q11.23 SyndromeVasculopathy
Hospices Civils de Lyon 90
Not applicableNo Longer AvailableNCT02624570
What this trial is testing

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML) WithFLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT06930417
What this trial is testing

Characterization and Natural History of Williams Syndrome and Other Chromosome 7q11.23 Variants

Who this might be right for
Williams Beuren SyndromeWilliams SyndromeWilliams Beuren Region Duplication+1 more
University of Pennsylvania 2,000
Not applicableStudy completedNCT02867891
What this trial is testing

Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial

Who this might be right for
Acute Myeloid Leukemia
Robert Zeiser 396
Not applicableUnknownNCT05596968
What this trial is testing

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAllogeneic Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 37
Not applicableNo Longer AvailableNCT05918913
What this trial is testing

Expanded Access Program for Revumenib

Who this might be right for
Relapsed/Refractory Acute Leukemia
Syndax Pharmaceuticals
Not applicableUnknownNCT02617108
What this trial is testing

Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

Who this might be right for
Uterine Septum
Fu Xing Hospital, Capital Medical University 310
Testing effectiveness (Phase 2)Active Not RecruitingNCT04201457
What this trial is testing

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

Who this might be right for
Low Grade Glioma (LGG) of Brain With BRAF AberrationHigh Grade Glioma (HGG) of the Brain With BRAF AberrationLow Grade Glioma of Brain With Neurofibromatosis Type 1
Pediatric Brain Tumor Consortium 57
Next Page